New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sabra Healthcare REIT, Inc.

SBRA

Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+22.2%
Free cash flow
n/m
Total debt
−5.99%

Quarter to September 2026, against a year earlier

20.39 0.07 −0.34%

After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.

Market cap
$5.4B
P/E
72.8×
Fwd P/E FY26e
62.6×
Dividend yield
5.89%
F-score
5/9
ROIC
1.95%
Net debt / EBITDA
5.5×
Payout ratio
4.3×

Revenue to profit Fiscal 2025, year to Dec 31, 2025

Of every $100 of revenue, $20.08 was left as profit. What is an income statement?

Revenue to profit, in millions of dollars and as a share of revenue
Revenue774.6100.0%
Cost of revenue0.00.0%
Gross profit774.6100.0%
Selling, general & admin−53.7−6.9%
Other operating costs−464.4−59.9%
Operating income256.533.1%
Other income, net−103.1−13.3%
Income tax−1.8−0.2%
Other items+3.90.5%
Net income155.520.1%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue$261M$408M$623M$662M$599M$570M$625M$648M$703M$775M
Operating income$132M$195M$305M$218M$252M$201M$141M$207M$239M$257M
Net income$70M$158M$279M$69M$138M−$113M−$78M$14M$127M$156M
Net margin (right axis)26.9%38.8%44.8%10.4%23.1%−19.9%−12.4%2.1%18.0%20.1%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
774.63 703.24 647.51 624.81 569.55 598.57 661.74 623.41 408.28 260.53
Revenue Growth
10.15% 8.61% 3.63% 9.70% (4.85%) (9.55%) 6.15% 52.69% 56.71% 9.07%
Gross Profit
774.63 703.24 647.51 624.81 569.55 598.57 661.74 623.41 408.28 260.53
Operating Income
256.55 238.56 207.19 140.66 201.25 251.67 217.77 304.90 195.44 132.13
EBT
153.42 128.11 18.66 21.67 80.67 155.73 79.22 287.56 159.02 71.25
Income after Tax
151.58 127.11 16.65 20.43 78.83 155.02 75.81 284.55 158.37 70.21
Net Income Common
155.61 126.71 13.76 (77.60) (113.26) 138.42 69.00 269.31 148.14 60.03
EPS (Diluted)
0.64 0.54 0.06 (0.34) (0.52) 0.67 0.37 1.51 1.40 0.92
Shares (Diluted, Weighted)
244.50 236.05 232.79 230.95 219.07 207.25 188.13 178.72 105.84 65.52
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBIT Margin
33.12% 33.92% 32.00% 22.51% 35.34% 42.04% 32.91% 48.91% 47.87% 50.72%
Net Profit Margin
20.09% 18.02% 2.12% (12.42%) (19.89%) 23.12% 10.43% 43.20% 36.28% 23.04%
Free Cash Flow Margin
(7.38%) 30.63% 59.43% 41.03% 55.31% 38.64% 94.44% 72.82% (34.49%) 45.81%
EBITDA
443.54 408.18 390.27 328.44 380.24 428.40 399.32 496.28 309.33 200.60
EBIT
256.55 238.56 207.19 140.66 201.25 251.67 217.77 304.90 195.44 132.13

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026